• Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease

  • Feb 24 2025
  • Duración: 9 m
  • Podcast

Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease

  • Resumen

  • Dr Bryant England discusses the use of TNF-inhibitor versus non-TNF inhibitor biological or targeted synthetic DMARDs for treatment of rheumatoid arthritis-associated ILD, and the effects on survival and respiratory hospitalisation outcomes.

    Read the full article:

    https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00265-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanrhe

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Más Menos
adbl_web_global_use_to_activate_webcro805_stickypopup

Lo que los oyentes dicen sobre Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.